Analyst ratings and price target adjustments are significant drivers of stock price movements. UBS's downgrade from Buy to Neutral suggests a less optimistic outlook on LXU's financial performance or valuation, which can lead to a decrease in investor confidence and selling pressure. The reduction in the price target from $11 to $9 further indicates a lowered expectation of the stock's future value, potentially leading to a negative short-term impact on the stock price.